MDS Analytical Technologies

MDS Analytical Technologies was a prominent global provider of high-performance analytical instrumentation and software solutions for the life sciences and drug discovery markets. Formed through the integration of MDS Sciex and the acquired Molecular Devices Corporation, the company specialized in mass spectrometry, high-throughput screening, and cellular analysis. Its technology platforms, such as the Triple Quad and QTRAP systems, became industry standards for proteomics, metabolomics, and clinical research. In 2010, the division was acquired by Danaher Corporation for $1.1 billion, leading to the creation of AB SCIEX and the continuation of Molecular Devices as independent operating companies within Danaher. The company's legacy remains central to modern bioanalytical workflows and pharmaceutical development.